.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

On the HCC Treatment Horizon

EP. 1: Hepatocellular Carcinoma: A Changing Treatment Landscape

February 9th 2018

EP. 2: REFLECT Trial: Frontline Lenvatinib's Value in HCC

February 9th 2018

EP. 3: CELESTIAL Trial: Second-Line Cabozantinib's Value in HCC

February 9th 2018

EP. 4: Immunotherapy Approaches in Hepatocellular Carcinoma

February 9th 2018

EP. 5: KEYNOTE-224: Second-Line Pembrolizumab

February 9th 2018

EP. 6: Locoregional Approaches in Hepatocellular Carcinoma

February 9th 2018

EP. 7: The Future of Treatment in Hepatocellular Carcinoma

February 9th 2018